[연관 대한신경과학회지 발표 문헌] DOI: https://doi.org/10.17340/jkna.2021.3.4

Professor Sung Hoon Kang

Audio. Lecanemab: shaping the present and future of Alzheimer’s disease treatment in Korea.

The Alzheimer’s disease treatment lecanemab has garnered significant attention as a groundbreaking therapy since its introduction in Korea in late 2024, due to its ability to intervene in the core amyloid pathology of the disease and slow its progression [1,2]. In this interview, we are joined by Professor Sung Hoon Kang, a dementia specialist at Korea University Guro Hospital, who has extensive clinical experience with lecanemab in real-world Alzheimer’s disease cases. We discuss the drug’s mechanism of action, indications, administration and monitoring strategies, as well as actual patient cases [3-5].